SANTA BARBARA — February, 20th, 2024 — Physicians who treat patients with Autosomal Dominant Polycystic Kidney Disease, or ADPKD, look forward to the results of a new clinical study, Santa Barbara Nutrients announced today. Tokyo’s Juntendo University has begun testing the long-term...
As Thomas Weimbs, PhD, a Professor of Molecular, Cellular, and Developmental Biology at the University of California, Santa Barbara, and Chief Scientific Officer for Santa Barbara Nutrients, explained, “Medical foods consist of substances ‘generally recognized as safe’ or GRAS by the...
SANTA BARBARA, Calif., October 9, 2023 (Newswire.com) – Santa Barbara Nutrients, Inc. is pleased to announce that our medical food product, KetoCitra®, will be utilized in a pilot clinical trial for patients with long-COVID. The trial will be led by faculty...
The KETO-ADPKD study is a landmark in the field of nephrology and nutrition, demonstrating improved kidney function as shown by statistically significant increases in eGFR in people with PKD adopting a ketogenic diet. This research helps to bridge the gap...
Santa Barbara Nutrients was a proud sponsor of the FASEB PKD Conference this year Why are we sponsoring PKD conferences? Being a sponsor at conferences and PKD events aligns with our purpose at Santa Barbara Nutrients. As a benefit corporation,...
